Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 1, 1999, Pages 165-172

  Rose, Jed E ^a,b   Westman, Eric C ^a,b   Behm, Frederique M ^b   Johnson, Mark P ^b   Goldberg, Joel S ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Addiction; Antagonist; Nicotine; Smoking; Trimethaphan

Indexed keywords

NICOTINIC RECEPTOR BLOCKING AGENT; TRIMETAPHAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART RATE; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; BLOOD PRESSURE; FEMALE; HEART RATE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC ANTAGONISTS; PERSONAL SATISFACTION; REWARD; SMOKING; TRIMETHAPHAN;

NICOTIANA TABACUM;

EID: 0032906512     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00153-1     Document Type: Article

References (40)

1. Abacus Concepts.: SuperANOVA. Berkeley: Abacus Concepts, Inc.; 1989.
2. Adams A.P., Hewitt P.B. Clinical pharmacology of hypotensive agents. Int. Anesthesiol. Clin. 20:1982;95-109.
3. Behm F.M., Schur C., Levin E.D., Tashkin D.P., Rose J.E. Clinical evaluation of a citric acid inhaler for smoking cessation. Drug Alcohol Depend. 31:1993;131-138.
4. Benowitz N.L., Porchet H., Jacob P.I. Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. Wonnacott S., Russell M.A.H., Stolerman I.P. Nicotine psychopharmacology. 1990;112-157 Oxford University Press, Oxford.
5. Bowman W.C., Rand M.J. Textbook of pharmacology. 1980;Blackwell Scientific Publication, London.
6. Butschky M.F., Bailey D., Henningfield J.E., Pickworth W.B. Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers. Pharmacol. Biochem. Behav. 50:1995;91-96.
7. Clarke P.B.S. The central pharmacology of nicotine. Electrophysiological approaches Wonnacott S., Russell M.A.H., Stolerman I.P. Nicotine psychopharmacology. Molecular, cellular, and behavioural aspects:1990;158-193 Oxford University Press, New York.
8. Corrigall W.A., Coen K.M., Adamson K.L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res. 653:1994;278-284.
9. Gilbert D.G., Jensen R.A., Meliska C.J. A system for administering quantified doses of tobacco smoke to human subjects. Plasma nicotine and filter pad validation Pharmacol. Biochem. Behav. 31:1989;905-908.
10. Ginzel K.H., Eldred E. Reflex depression of somatic motor activity from heart, lungs and carotid sinus. Paintal A.S., Gill-Kumar P. Krogh centenary symposium on respiratory adaptation, capillary exchange and reflex mechanisms. 1977;358-395 Vallabhbai Patel Chest Institute, University of Delhi, Delhi.
11. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;713-716.
12. Gross P.M., Wall K.M., Pang J.J., Shaver S.W., Wainman D.S. Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius. Am. J. Physiol. 259:1990;R1131-R1138.
13. Hasenfratz M., Baldinger B., Battig K. Nicotine or tar titration in cigarette smoking behavior? Psychopharmacology (Berlin). 112:1993;253-258.
14. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström test for nicotine dependence. A revision of the Fagerström tolerance questionaire Br. J. Addict. 86:1991;1119-1127.
15. Herskovic J.E., Rose J.E., Jarvik M.E. Cigarette desirability and nicotine preference in smokers. Pharmacol. Biochem. Behav. 24:1986;171-175.
16. Horan J.J., Hackett G., Linberg S.E. Factors to consider when using expired air carbon monoxide in smoking assessment. Addict. Behav. 3:1978;25-28.
17. Jafri, M. S.; Kamatchi, G.; Kao, J. P. Y.; Weinrich, D.: Nicotinic receptors mediate a calcium-dependent decrease in membrane excitability in vagal afferents in vitro. Poster presentation at the Society for Neurosciences meeting, New Orleans, LA, October 25-30, 1997.
18. Keppel G. Design and analysis. A researcher's handbook 2:1982;Prentice Hall, Inc, Englewood Cliffs, NJ.
19. Khan I.M., Marsala M., Printz M.P., Taylor P., Yaksh T.L. Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats. J. Pharmacol. Exp. Ther. 278:1996;97-106.
20. Klowden A.J., Ivankovitch A.D., Miletich D.J. Ganglionic blocking drugs. General considerations and metabolism Int. Anesthesiol. Clin. 16:1978;113-150.
21. Koob G.F., Nestler E.J. The neurobiology of drug addiction. J. Neuropsychol. Clin. Neurosci. 9:1997;482-497.
22. Lee L.-Y., Gerhardstein D.C., Wang A.L., Burki N.K. Nicotine is responsible for the airway irritation evoked by cigarette smoke inhalation in men. J. Appl. Physiol. 75:1993;1955-1961.
23. Levin E.D., Rose J.E., Behm F. Controlling puff volume without disrupting smoking topography. Behav. Res. Methods Instrum. Comput. 21:1989;383-386.
24. Maxwell S.E., Delaney H.D. Designing experiments and analyzing data. 1990;Wadsworth, Belmont, CA.
25. McGehee D.S., Heath M.J.S., Gelber S., Devay P., Role L.W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 269:1995;1692-1696.
26. Pontieri F.E., Tanda G., Orzi F., Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature. 382:1996;255-257.
27. Rose J.E. The role of upper airway stimulation in smoking. Pomerleau O.F., Pomerleau C.S. Nicotine replacement. A critical evaluation:1988;95-106 Alan R. Liss, Inc, New York.
28. Rose J.E., Behm F.M. There is more to smoking than the CNS effects of nicotine. Effects of nicotine on biological systems II. 1995;Burkhäuser Verlag, Basel. 9-16.
29. Rose J.E., Behm F.M., Westman E.C., Levin E.D., Stein R.M., Lane J.D., Ripka G.V. Combined effects of nicotine and mecamylamine in attenuating smoking satisfaction. Exp. Clin. Psychopharmacol. 2:1994;1-17.
30. Rose J.E., Behm F.M., Westman E.C., Levin E.D., Stein R.M., Ripka G.V. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin. Pharmacol. Ther. 56:1994;86-99.
31. Rose J.E., Corrigall W.A. Nicotine self-administration in animals and humans. Similarities and differences Psychopharmacology (Berlin). 130:1997;28-40.
32. Rose J.E., Hickman C.S. Citric acid aerosol as a potential smoking cessation aid. Chest. 92:1987;1005-1008.
33. Rose J.E., Levin E.D. Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking. West R., Grunberg N.E. British journal of addiction. 1991;605-610 Carfax Publishing Company, London.
34. Rose J.E., Westman E.C., Behm F.M. Nicotine/mecamylamine combination treatment for smoking cessation. Drug Dev. Res. 38:1996;243-256.
35. Shiraki T., Toyoda A., Sugino H., Hori A., Kobayashi S. Possible nicotinic receptor-mediated modulation of synaptic transmission in nucleus of the solitary tract. Am. J. Physiol. 41:1997;R869-R873.
36. U.S.D.H.H.S.: The health consequences of smoking: Nicotine addiction. Rockville, MD: Office on Smoking and Health; 1988.
37. Weaver W.R., Wolf K.M., Chiappinelli V.A. Functional heterogeneity of nicotinic receptors in the avian lateral spiriform nucleus detected with trimethaphan. Mol. Pharmacol. 46:1994;993-1001.
38. Westman E.C., Behm F.M., Rose J.E. Airway sensory replacement as a treatment for smoking cessation. Drug Dev. Res. 38:1996;257-262.
39. Westman E.C., Levin E.D., Rose J.E. Smoking while wearing the nicotine patch. Is smoking satisfying or harmful? Clin. Res. 40:1992;871A.
40. Wonnacott S. Characterization of nicotine receptor sites in the brain. Wonnacott S., Russell M.A.H., Stolerman I.P. Nicotine psychopharmacology. Molecular, cellular, and behavioural aspects:1990;226-277 Oxford University Press, New York.